Skip to content

Repetitive Transcranial Magnetic Stimulation Targeting Multiple Neural Networks for Freezing Gait of Parkinson's Disease

Imaging genetic mechanisms of repetitive transcranial magnetic stimulation targeting multiple neural networks to intervene in freezing gait in Parkinson's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098858
Enrollment
Unknown
Registered
2025-03-14
Start date
2025-03-14
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Intervention Movement Network Group:rTMS high-frequency stimulation of the supplementary motor area (SMA) of the brain
Intervention Cognitive Network Group:rTMS high-frequency stimulation of the dorsolateral prefrontal cortex (DLPFC) of the brain
Intervention Emotions Network Group:rTMS high-frequency stimulation of the medial prefrontal cortex of the brain

Sponsors

Department of Neurology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Patients with PD: 1. Meet the 2015 MDS version of PD diagnostic criteria; 2. Age 30-80 years old; 3. Right hand; 4. There is no restriction on gender and course of disease; 5. Voluntarily participate in the study and sign the informed consent form; 6. Able to complete all clinical assessments, peripheral blood sample collection, head MRI scans and rTMS treatments. Inclusion Criteria for Healthy Control Subjects: 1. Gender, age, and handicraft match the patient group; 2. Able to cooperate to complete cognitive assessments; 3. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for Patients with PD: 1. Unable to cooperate with MRI scan and rTMS treatment due to severe disease; 2. There are metal implants and other contraindications for MRI examination and rTMS treatment in vivo; 3. History of intracranial mass, hydrocephalus, head trauma, craniocerebral surgery, stroke, intracranial infection and other neurological diseases; 4. Abnormal signals on ordinary T1 and T2-weighted MRI examinations; 5. Comorbid psychiatric disorders; 6. Refusal of follow-up or assessment Exclusion Criteria for Healthy Control Subjects: 1. Comorbid neurological diseases; 2. Combined with severe mental illness and physical illness.

Design outcomes

Primary

MeasureTime frame
Clinical scale scores;Functional magnetic resonance imaging (MRI).;

Countries

China

Contacts

Public ContactRuwei Ou

West China Hospital, Sichuan University

ouruwei@aliyun.com+86 157 0846 5199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026